Pillstats
Rx only · Injection, Suspension, Liposomal · Intravenous

Doxorubicin Hydrochloride

Brands: Doxil · Doxorubicin Hydrochloride

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3639
US makers6 labelers
Packages18
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

511021542052025 Q12025 Q22025 Q32025 Q42026 Q1
129
Rx · 2026 Q1
2.9K
Units dispensed
+15%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown4SUPPLYING
Baxter Healthcare Corporationunknown4SUPPLYING
BluePoint Laboratoriesunknown4SUPPLYING
Dr.Reddy's laboratories Limitedunknown2SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 24, 2023
    RECALLRecall (Class II): Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manufactured …

    CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake. — Recalling firm: Baxter Healthcare Corporation — Nationwide in the USA